Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: Assessment using contrast-enhanced ultrasound

British Journal of Radiology

Volumn 81, Issue 962, 2008, Pages 113-119

  Zhou, J H ^a   Li, A H ^a   Cao, L H ^a   Jiang, H H ^a   Liu, L Z ^a   Pei, X Q ^a   Han, F ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SONOVUE; CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMODYNAMICS; HEPATIC ARTERY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; LIVER BLOOD FLOW; LIVER HEMODYNAMICS; LIVER METASTASIS; LIVER VEIN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MICROMETASTASIS; BLOOD FLOW; CASE CONTROL STUDY; ECHOGRAPHY; LIVER TUMOR; METASTASIS; MICROBUBBLE; MIDDLE AGED; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; HEMODYNAMICS; HEPATIC ARTERY; HEPATIC VEINS; HUMANS; LIVER NEOPLASMS; MALE; MICROBUBBLES; MIDDLE AGED; PHOSPHOLIPIDS; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 39549098332     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/25294912     Document Type: Article

References (26)

1. Yarmenitis SD, Kalogeropoulou CP, Hatjikondi O, Ravazoula P, Petsas T, Siamblis D, et al. An experimental approach of the Doppler perfusion index of the liver in detecting occult hepatic metastases: histological findings related to the haemodynamic measurements in Wistar rats. Eur Radiol 2000;10:417-24.
2. Oxley EM, Eills H. Prognosis of carcinoma of large bowel in the presence of liver metastases. Br J Surg 1969;56:149-52.
3. Robinson PJA. Imaging liver metastases: current limitations and future prospects. Br J Radiol 2000;73:234-41.
4. Leveson SH, Wiggins PA, Giles GR, Parkin A, Robinson PJ. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg 1985;72:128-30.
5. Totman JJ, O'Gorman RL, Kane PA, Karani JB. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer. Br J Radiol 2005;78:105-9.
6. Leen E, Goldberg JA, Robertson J, Angerson WJ, Sutherland GR, Cooke TG, et al. Early detection of occult colorectal hepatic metastases using duplex colour Doppler sonography. Br J Surg 1993;80:1249-51.
7. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cook TG, McArdle CS. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology 1995;195:113-16.
8. Leen E, Angerson WG, Cooke TG, McArdle CS. Prognostic power of doppler perfusion index in colorectal cancer correlation with survival. Ann Surg 1996;223:199-203.
9. Roumen RM, Scheltinga MR, Slooter GD, van der Linden AW. Doppler perfusion index fails to predict the presence of occult hepatic colorectal metastases. Eur J Surg Oncol 2005;31:521-7.
10. Blomley MJK, Albrecht T, Cosgrove DO, Jayaram V, Eckersley RJ, Patel N, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in 7 patients with metastases. Radiology 1998;209:862-6.
11. Bernatik T, Becker D, Neureiter D, Hansler J, Frieser M, Schaber S, et al. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol 2004;16:313-17.
12. Nott DM, Grime SJ, Yates J, Day DW, Baxter JN, Jenkins SA, et al. Changes in hepatic perfusion index during the development of experimental hepatic tumours. Br J Surg 1989;76:259-63.
13. Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004;231:482-90.
14. Bang N, Nielsen MB, Rasmussen AN, Osterhammel PA, Pedersen JF. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Br J Radiol 2001;74:752-5.
15. Albrecht T, Blomley MJK, Cosgrove DO, Taylor-Robinson SD, Jayaram V, Eckersley R, et al. Non-invasive diagnosis of hepatic cirrhosis by transit time analysis of an ultrasound contrast agent. Lancet 1999;353:1579-83.
16. Blomley MJK, Lim AKP, Harvey CJ, Patel N, Eckersley RJ, Basilico R, et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: A cross-sectional study. Gut 2003;52:1188-93.
17. Lim AKP, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, et al. Hepatic vein transit times using a microbubble agent can predict disease severity noninvasively in patients with hepatitis C. Gut 2005;54:128-33.
18. Ellis LM, Fidler IJ. Angiogenesis and metastasis. Eur J Cancer 1996;32A:2451-60.
19. Lin G, Lunderquist A, Hagerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 1984;96:517-26.
20. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM. Perfusion of colorectal hepatic metastases: relative distribution of flow from the hepatic artery and portal vein. Cancer 1987;59:1547-53.
21. Goldberg JA, Thomson JAK, Mccurrach G, Anderson JH, Willmott N, Bessent RG, et al. Arteriovenous shunting in patients with colorectal liver metastases. Br J Cancer 1991;63:466-8.
22. Yamada S, Komuro K, Mikami T, Kudo N, Onozuka H, Goto K, et al. Novel quantitative assessment of myocardial perfusion by harmonie power Doppler imaging during myocardial contrast echocardiography. Heart 2005;91:183-8.
23. Harvey CJ, Blomley MJK, Eckersley RJ, Cosgrove DO. Developments in ultrasound contrast media. Eur Radiol 2001;11:675-89.
24. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001;11:1316-28.
25. Cosgrove D, Eckersley R, Blomley M, Harvey C. Quantification of blood flow. Eur Radiol 2001;11:1338-44.
26. Lim AKP, Patel N, Eckersley RJ, Goldin RD, Thomas HC, Cosgrove DO, et al. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006;240:130-5.